Press Releases
November 5, 2024
Fidelis Animal Health, Inc. Announces Major Label Expansion for Ethiqa XR®
Ethiqa XR, an extended-release buprenorphine, adds captive rodents and laboratory rabbits to label for 72-hour control of post-procedural pain.


